Physician profile
Candace E Huffmaster
NPI 1124445960
$247.29
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.99 · 2022: $93.16 · 2023: $61.98 · 2024: $29.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $48.87 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $34.53 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.03 | 2023-2024 | Andexxa |
| Depuy Synthes Sales INC. | $20.70 | 2021 | |
| Integra Lifesciences Corporation | $20.69 | 2022 | |
| Mallinckrodt Hospital Products INC. | $19.48 | 2022 | |
| Shionogi INC | $18.29 | 2023 | Fetroja |
| Paratek Pharmaceuticals, INC. | $16.92 | 2021 | |
| Smith+Nephew, INC. | $15.41 | 2024 | Collagenase Santyl, Renasys Touch, Oasis |
| Teleflex LLC | $12.74 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Huffmaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.